Population health-based chronic care models of care are useful in improving the health of a population while decreasing the health care dollars spent on the population. Diabetes is a disease that can be evaluated and treated using these models of care. The Metro Nashville Public Schools Diabetes Health Management Program has been shown to be beneficial to both clients and their insurance trust in improving the health of this population of individuals and decreasing the dollars spent on this disease.
Nurse practitioners can focus on the primary prevention of diabetes in their role as primary care providers (Ohman-Strickland et aI., 2008) and can partner with employees to encourage appropriate lifestyle modifications and control of disease. Increased physical activity and modest weight reduction, as recommended by primary care providers, resulted in the prevention of type 2 diabetes mellitus by 58% in the general population and 71% among those older than 60 years in the Diabetes Prevention Program (Pearson, Pronk, Tan, & Halstenson, 2003) . A population health approach with systematic changes was found useful in this study to modify risk factors of the population studied. Population health management seeks to manage health care and the health of chronically ill individuals: this approach goes beyond the traditional health care model of managing disease (Howe & Spence, 2009) .
The Chronic Care Model (CCM) of health care is an organizational approach for primary care providers to care for clients with chronic illness. This model of care differs from the traditional model of acute episodic care provided by most primary care providers (Nutting et aI., 2007) . The Population Health Model (PHM) and the CCM are used together to provide care in the MNPS Healthcare Centers. The CCM is used to improve clinical outcomes and is effective in the care of diabetes (Nutting et aI., 2007) . Included in the CCM is active continued monitoring to ensure progress toward client goals and modifying care as needed to meet those goals (Better Diabetes Care, 2009 ).
The MNPS Healthcare Centers developed a Diabetes Health Management Program (DHMP) to address the issues of clients (I) at risk for diabetes, (2) with undiagnosed diabetes, and (3) with previously diagnosed type I and type 2 diabetes. The goal of the program was to address the health of teachers and decrease health care costs for those with diabetes and those at risk for diabetes by using a population health and chronic disease management model of care.
The purpose of this article is to describe the DHMP and share the successes of the program's first year. This article may encourage employers to use similar programs to improve the health of employees and decrease the cost of caring for employees with chronic diseases.
BACKGROUND AND SIGNIFICANCE
The purpose of this program evaluation was to determine the value of the DHMP of the MNPS Healthcare Centers instituted August I, 2009. Program evaluations are necessary to determine the efficacy of programs and identify areas for program improvement (Northwest Health Foundation, 2005) . The aim of this evaluation was to determine the success of the program as demonstrated by core evaluation measures.
Employees with diabetes often cite out-of-pocket expenses (i.e., co-pays for equipment and medication) as a reason for not adhering to treatment (Spaulding et al., 2009) . Employers acknowledge these expenses for employees and know that controlling employees' diabetes is paramount in decreasing costly complications and absenteeism and maintaining or increasing productivity. Many employers are now participating in value-based therapies because these therapies have been shown to prevent complications, maintain health, decrease absenteeism, and improve productivity (Spaulding et al., 2009) .
MNPS had a self-insured insurance trust managed by the benefits department and insurance trust board and administered by BCBS in 2009 and 2010 for certified teachers and their families. The insurance trust was funded by insurance premiums paid by MNPS and the teachers. To decrease or stabilize health care costs, MNPS opened five health care centers staffed by family nurse practitioners to provide on-site, convenient, quality health care for the individuals covered under this plan.
POPULATION HEALTH MODEL
Although most health care center staff are interested in treating disease processes, these health care centers treated disease processes using a PHM to prevent disease and encourage wellness. PHM improves and manages the health of chronically ill employees as well as those at risk for disease (Howe & Spence, 2009) . Disease management includes managing complications and providing interventions such as medications; health management integrates care of a physiologic system and entire client populations (Peterson, 1997) .
The PHM for the health care centers consists of health management programs for chronic diseases. The first health management program developed for the MNPS employees was the DHMP. The philosophy of this program is that health management should be populationbased and must manage health risks as well as disease and costs. The purpose of this program was to identify employees at risk for diabetes, prevent at-risk members from developing diabetes, and prevent disease progression in those with diabetes. It was expected that these three interventions could improve the management of diabetes in this population.
THEORETICAL FOUNDATION
Disruptive innovations in health care, as explained by Christensen, Bohmer, and Kenagy (2000) , describe this program. Christensen et al. (2000) refer to disruptive innovations as less expensive, simpler, and more convenient, meeting the needs of customers who are less demanding (e.g., an individual with controlled type 2 diabetes and hypertension is less demanding of health care services than an individual with uncontrolled type 2 diabetes and hypertension, renal insufficiency, and congestive heart failure). The theory of disruptive innovations includes the process by which expensive and complicated services are transformed into more affordable ones (Christensen, Grossman, & Hwang, 2009 ). Companies typically improve products at a faster pace so that products that once were not good enough are improved to a point of actually being too good (e.g., specialists, rather than primary care providers, caring for diabetes). A disruptive innovation is not a breakthrough improvement but rather a simpler, more affordable innovation. Christensen et al. (2009) believe health care has exceeded the needs of most clients with technology and specialization and recommend allowing less expensive professionals (e.g., nurse practitioners) to offer more services in less expensive settings. This program uses the theory of disruptive innovation by employing less expensive providers (e.g., nurse practitioners rather than physicians) at less costly locations (e.g., MNPS Healthcare Centers) with no compromise in quality of care or convenience (Christensen et al., 2009 ).
REVIEW OF THE LITERATURE
Disease management programs focus on high-risk individuals who impact health care costs and are offered by employers more often than health promotion programs due to the larger return on investment (Pelletier, 2009). Pelletier reviewed clinical and cost-effectiveness studies of health promotion and disease management programs conducted at corporate worksites. The review supported disease management programs combining comprehensive interventions and high-risk interventions focusing on increasing levels of intensity as the future direction for worksite programs.
PHM directs treatment of the sick, including disease management and risk management, for the whole eli-ent and population (Peterson, 1997) . Population health focuses on improving the health of the population and, therefore, reducing the cost of health care for the population. The PHM for MNPS Healthcare Centers is aimed at improving the health of the population of MNPS teachers and their families. Specifically, this health management program improves the health of those diagnosed with diabetes and those at risk for diabetes, delaying or preventing the onset of diabetes.
PHM as developed in this DHMP is a disruptive innovation compared to traditional care of diabetes by physicians. The program is provided by nurse practitioners, licensed practical nurses, and medical assistants. The program is based on the American Diabetic Association's (ADA, 2009) Standards of Care. The participants in the program receive care with no co-pay for office visits and laboratory services at MNPS Healthcare Centers. Participants also receive diabetic medications and equipment at no cost.
Pelletier (2009) analyzed comprehensive health promotion and disease management programs at the worksite. The most significant finding was not whether worksites had disease management programs, but how the programs were designed, implemented, and evaluated to provide optimal clinical care and cost-effectiveness. Pelletier concluded that, although worksite disease management programs differed, the most effective programs had six best practice elements. These elements and their relationship to the DHMP included (I) organizational commitment; (2) incentives for employees to participate; (3) effective screening and triage; (4) state-of-the-art theory and evidence-based interventions; (5) effective implementation; and (6) ongoing program evaluation.
The benefits department for MNPS is interested in providing value-based care. For this reason, the decision was made to decrease the cost barrier for employees with diabetes. Evidence for value-based care is presented by Spaulding et al. (2009) in an article on value-based insurance design. The authors discuss the MHealthy: Focus on Diabetes (FOD) trial, which included 2,507 employees and dependents insured by a large employer. The control group included 8,637 employees with diabetes covered by other employers. The study demonstrated that copayments for medications adversely impacted adherence to medication regimens; data suggested that individuals who decrease medication use due to cost have poorer health outcomes and incur higher health care costs. Altering or decreasing co-payments presents an incentive for employees to participate in care and is aimed at those who benefit most from therapy. This approach maximizes health returns and decreases spending, thereby increasing the value of therapies.
The 2009 ADA Standards of Care were used for the DHMP. These standards describe care of clients with diabetes and at risk for diabetes. The recommendations include an annual examination with a foot examination, dilated eye examination, depression screening, and several laboratory tests (i.e., lipid panel, Al c, liver function, and urine for micro albuminuria). The ADA further recommends clients with diabetes be examined by their health AAOHN JOURNAL' VOL. 59, NO. 12, 2011 care provider every 3 months for evaluation and consultation regarding self-care, home glucose monitoring, visual foot examination, and Alc stability.
METHODOLOGY
The DHMP was evaluated to determine the success of the program and areas in need of improvement. Those enrolled in the program were compared to those not enrolled in the program in terms of cost for the year prior to the program and cost at the end of the first year of the program, number of provider visits for both years, number of prescriptions and cost of prescriptions, number of hospital days for each group, number of emergency visits for each group, and enrollees' A I c levels at the end of the first year.
The MNPS Healthcare Centers implemented the DHMP August l , 2009. Participants scheduled an initial appointment at one of the MNPS Healthcare Centers to enroll in the program. At this appointment, the program was explained to the employees. The employees were made aware that by enrolling they were agreeing to annual diabetic examinations and that they must schedule appointments with their health care provider every 3 months for a diabetes evaluation.
If they agreed, employees received all of their diabetic medications and equipment with no co-pay. They could choose to be followed at the MNPS Healthcare Center with no co-payor could continue care with their primary care provider. During the visit with the nurse practitioner, if employees chose to continue treatment with their primary provider, they were given a letter for providers describing the program and a release of information form so providers could send the employees' reports every 3 months to the population health manager responsible for monitoring employee care. The population health manager is a member of the MNPS Employee and Family Healthcare Center's professional staff.
The overall goal of the evaluation was to determine the effectiveness and efficiency of the diabetes disease management program. Effectiveness was evaluated by determining whether the interventions in this program produced better outcomes than those identified prior to the initiation of the program. Efficiency was evaluated by determining the cost-effectiveness of this program (Institute of Medicine, 2008) .
The core evaluation measures were:
• Improvement of or decline in Alc measures (7 or below).
• The number of enrollees active in the DHMP by the end of year one.
• Comparison of diabetes-associated costs for the year prior to and the year after initiation of the program by:
I. Measuring the number of visits to health care providers.
2. Measuring pharmacy use and adherence. 3. Measuring overall health care expenditures for clients with diabetes.
Data were collected from BCBS about physician office visits, pharmacy use and compliance, and health care 
RESULTS
The DHMP population had an average age of 59 years and was 30% male and 70% female. The entire population covered by the MNPS health trust had an average age of 52 years and was 36% male and 64% female.
Within the first 3 months (August I through October 31, 2009), 228 employees with diabetes enrolled in the expenditures. The electronic medical record used by the health care centers provided data such as A1c measures and employees enrolled in the diabetic disease management program. Data were de-identified to protect the privacy of employees and comply with Health Insurance Portability and Accountability Act regulations .
The core measures were evaluated at the end of the first year of the program. Data from the evaluations were used to compare core measures to the year prior to the implementation of the program.
program. Of this group, more than one laboratory value was captured for 20 I enrollees . The hemoglobin A Ic levels for the population were categorized into three groups: controlled-Alc of less than 7; problematic-Alc between 7 and 8.9; and severe-Alc of9 or greater.
Participants are monitored and A Ic values reported while in the program. Of the original enrollees, subsequent laboratory values for 20 I members were measured, with 64 of the laboratory values reported after the first 12 months of participation (months 13 to 15). These values were used to provide the most current snapshot of outcomes. The most significant change occurred in the 29 original enrollees in the severe group ; of this group, only 12 (41%) remained at the severe level at the end of the period. The problematic group consisted of 76 members; 31% improved to controlled and 5% declined to severe. Of the 94 members of the controlled group, 84% remained controlled; 15% moved to problematic and 1% to severe (Fig. I) .
The financial impact was evaluated using claims data captured for the enrolled and the non-enrolled diabetic population for 12 months before and 12 months after program implementation. At a cost of $5,830 per year (plan payment), the initial group's cost was 31% lower than the control group ($8,492) . At the end of the first year of the program, the variance between the enrollees and the control group increased to 43%, increasing the cost gap from $2,661 to $4,539 per individual with diabetes.
Costs were divided into five categories : emergency room (ER), outpatient hospital (OP), inpatient hospital (IP), physician services (MD), and pharmacy (RX) (Table) . In all five areas, the enrollees ' costs remained lower than the control group's costs during the 2-year period.
In the first year of the program, enrollees incurred a 5% increase in cost, including a 10% rise in RX costs. In the same period, the control group experienced a 26% increase in costs, including an II % increase in RX costs.
Return on investment is the difference in cost increase between the two groups . By effective management of risks in the enrolled population, cost trends have been reduced. If enrollee costs had increased at the same rate as the control group costs (26%), the plan would have incurred an additional annual cost of $1,194 per member, or $261,470 for the 219 members. Program costs are less than $50,000 annually; current enrollment exceeds 500 members.
One of the expected outcomes of this program was to increase provider visits; enrollees were required to visit a health care provider every 3 months. The ADA (2009) recommends visits to the provider every 3 months to provide support to the client, closely monitor A Ic values, and determine possible complications to prevent catastrophic results such as renal failure or blindness.
BCSS data from 2009 and 20 I0 indicated that provider visits for the first year of the DHMP, November 1, 2009, to November 1,2010, increased by 18 (or 1%) for enrollees and by 494 (or 24%) for those not enrolled. The cost of provider visits, even though the number had increased, was lower in the enrolled group. This result could be attributed to the migration of employees from 
BUDGET
The funding for this program was approved and provided by the board of the insurance trust prior to institution of the program. During the 12 months before program initiation, August 2008 to August 2009, diabetic members of the insurance trust spent $20,000 in co-insurance and deductibles for diabetic supplies. Using current drug utilization patterns, the projected cost of the co-payments for the entire diabetic population of trust members was approximately $260,000 for the next 12 months.
The prediction was that if 50% of eligible employees participated in the DHMP (805 participants), the cost of medication would increase by $150,000 and supplies by $20,000 due to waived co-pays . The cost of staffing was absorbed into the budget of the health care centers as no additional staff were added to the health care centers to provide this service. The cost for educational materials and mailings was not to exceed $25,000 annually. Thus, the total increase in cost to the insurance trust was $195,000, approximately $242 per employee.
The expectation was that the cost of this program would be offset by improved health of participants, which, in tum, would reduce health care costs. Additionally, savings were expected due to fewer complications, emergency department visits, and hospitalizations. outside primary care providers to the MNPS Healthcare Centers. The cost for provider visits per claim decreased by 9 % for enrollees and increased by 17% for those not enrolled.
The expected outcome for prescriptions was that the number would increase, as would the number of enrollees using prescriptions, because the co st barrier was removed. The results actually showed a de crease in prescription claims in the enrolled population of 131 (or -2 %), with a 10% increase in RX costs from the year prior to the program to the end of year one of the program. Non-enrolled RX claims increased by 265 , with an II % increase in cost from the year prior to the program to the end of year one of the program (BCBS , 2009 (BCBS , , 2010 (Fig. 2) .
Another DHMP expectation was that by the end of the first year, 50% (or 800) of the 1,600 known diabetics in this population would be enrolled in the program. By the end of the first year, 500 diabetics were enrolled in the DHMP.
SUMMARY
The DHMP is an innovative method of disease management. This program can be considered a disruptive innovation in the care of diabetes because program care is provided by nurse practitioners, a less expensive alternative to physicians or speciali sts. Because employees pay no out-of-pocket dollars to come to the MNPS Healthcare Center for care or for diabetic prescriptions or supplies , the program is also innovative. These qualities are consistent with the theory of di sruptive innovation described by Christensen et al. (2009) , as diabetes care provided freeof-charge to employees is not the norm in health care today. With the PHM and CCM of care, employees enrolled in the program receive high-quality care suited to their needs; they are given time with the nurse practitioner so that they do not feel rushed and can de velop a partnership with the nurse practitioner in managing their health care. The population of diabetics in the program receives consistent diabetic care based on ADA standards. Currently, 500 employees are enrolled in the program. To encourage participation in the program, several steps have been taken, including not charging clients covered by the insurance trust for laboratory tests during a visit to the health care center. The nurse practitioners are visiting schools and informing teachers about the program during lunch periods and staff meetings.
The value of this program for controlling the A Ic of enrolled employees has been shown by the decrease in the percentage of diabetic enrollees in the severe A Ic category from 15% to 8.5 % and the increase of controlled employee s from 48 % to 54 .2%. A minimal change from 37.5 % to 37 .3% occurred in the problematic group.
BCBS data (2010) indicated that in the first year of the program, prescription costs increased 10% for enrollees and II % for tho se not enrolled. The expectation was that prescription costs would increase more for enrollees.
It is thought that this did not occur because enrollees have better control of their disease and medications have been evaluated and changed to better control diabetes. It wa s understood that, initially, absorbing the co-pay of medi-McCarver, P.
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cations and supplies for diabetes would increase the cost to the insurance trust, but that, in the end, this benefit to employee s would save money for the insurance trust because employees would have fewer complications, hospitalizations, and catastrophic events. The enrolled group had fewer hospitalizations than the non-enrolled group prior to the program, but had significantly fewer than the non-enrolled group after year one of the DHMP. Health care costs for first-year enrollees increased by 5%, including a 10% increase in RX costs; the non-enrolled diabetic employees' health care costs increased 26%, including an II % increase in RX costs.
The DHMP began August I, 2009. The evaluation of year one of the program has shown that the program has been successful. Enrolled employees are using prescription s and reporting fewer hospitalizations and health care costs compared to non-enrolled employees. Costs are $5,830 per enrollee versus $8,492 per non-enrollee.
This evaluation has demonstrated the benefit of the program for enrollees' health by showing a decrease in Alc for the severe category of enrollee s and an increase in the number of controlled enrollees . The cost of the program has shown a significant savings to the MNPS insurance trust for those enrolled in the program compared to those not in the program.
